1
|
Chevalier Q, Gallé JB, Wasser N, Mazan V, Villette C, Mutterer J, Elustondo MM, Girard N, Elhabiri M, Schaller H, Hemmerlin A, Vonthron-Sénécheau C. Unravelling the Puzzle of Anthranoid Metabolism in Living Plant Cells Using Spectral Imaging Coupled to Mass Spectrometry. Metabolites 2021; 11:metabo11090571. [PMID: 34564386 PMCID: PMC8472718 DOI: 10.3390/metabo11090571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2021] [Revised: 08/16/2021] [Accepted: 08/23/2021] [Indexed: 12/02/2022] Open
Abstract
Vismione H (VH) is a fluorescent prenylated anthranoid produced by plants from the Hypericaceae family, with antiprotozoal activities against malaria and leishmaniosis. Little is known about its biosynthesis and metabolism in plants or its mode of action against parasites. When VH is isolated from Psorospermum glaberrimum, it is rapidly converted into madagascine anthrone and anthraquinone, which are characterized by markedly different fluorescent properties. To locate the fluorescence of VH in living plant cells and discriminate it from that of the other metabolites, an original strategy combining spectral imaging (SImaging), confocal microscopy, and non-targeted metabolomics using mass spectrometry, was developed. Besides VH, structurally related molecules including madagascine (Mad), emodin (Emo), quinizarin (Qui), as well as lapachol (Lap) and fraxetin (Fra) were analyzed. This strategy readily allowed a spatiotemporal characterization and discrimination of spectral fingerprints from anthranoid-derived metabolites and related complexes with cations and proteins. In addition, our study validates the ability of plant cells to metabolize VH into madagascine anthrone, anthraquinones and unexpected metabolites. These results pave the way for new hypotheses on anthranoid metabolism in plants.
Collapse
Affiliation(s)
- Quentin Chevalier
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Thérapeutique, Université de Strasbourg, CEDEX, F-67401 Illkirch, France; (J.-B.G.); (N.W.); (N.G.); (C.V.-S.)
- Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, Université de Strasbourg, CEDEX, F-67084 Strasbourg, France; (C.V.); (J.M.); (H.S.); (A.H.)
- Correspondence: ; Tel.: +33-367155265
| | - Jean-Baptiste Gallé
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Thérapeutique, Université de Strasbourg, CEDEX, F-67401 Illkirch, France; (J.-B.G.); (N.W.); (N.G.); (C.V.-S.)
| | - Nicolas Wasser
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Thérapeutique, Université de Strasbourg, CEDEX, F-67401 Illkirch, France; (J.-B.G.); (N.W.); (N.G.); (C.V.-S.)
| | - Valérie Mazan
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Moléculaire et Applications, Université de Strasbourg-Université de Haute Alsace, CEDEX, F-67087 Strasbourg, France; (V.M.); (M.E.)
| | - Claire Villette
- Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, Université de Strasbourg, CEDEX, F-67084 Strasbourg, France; (C.V.); (J.M.); (H.S.); (A.H.)
| | - Jérôme Mutterer
- Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, Université de Strasbourg, CEDEX, F-67084 Strasbourg, France; (C.V.); (J.M.); (H.S.); (A.H.)
| | | | - Nicolas Girard
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Thérapeutique, Université de Strasbourg, CEDEX, F-67401 Illkirch, France; (J.-B.G.); (N.W.); (N.G.); (C.V.-S.)
| | - Mourad Elhabiri
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Moléculaire et Applications, Université de Strasbourg-Université de Haute Alsace, CEDEX, F-67087 Strasbourg, France; (V.M.); (M.E.)
| | - Hubert Schaller
- Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, Université de Strasbourg, CEDEX, F-67084 Strasbourg, France; (C.V.); (J.M.); (H.S.); (A.H.)
| | - Andréa Hemmerlin
- Institut de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, Université de Strasbourg, CEDEX, F-67084 Strasbourg, France; (C.V.); (J.M.); (H.S.); (A.H.)
| | - Catherine Vonthron-Sénécheau
- Centre National de la Recherche Scientifique, Laboratoire d’Innovation Thérapeutique, Université de Strasbourg, CEDEX, F-67401 Illkirch, France; (J.-B.G.); (N.W.); (N.G.); (C.V.-S.)
| |
Collapse
|
2
|
Gallé JB, Attioua B, Kaiser M, Rusig AM, Lobstein A, Vonthron-Sénécheau C. Eleganolone, a diterpene from the French marine alga Bifurcaria bifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum. Mar Drugs 2013; 11:599-610. [PMID: 23442789 PMCID: PMC3705360 DOI: 10.3390/md11030599] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2012] [Revised: 01/18/2013] [Accepted: 02/07/2013] [Indexed: 11/17/2022] Open
Abstract
Organic extracts of 20 species of French seaweed have been screened against Trypanosoma brucei rhodesiense trypomastigotes, the parasite responsible for sleeping sickness. These extracts have previously shown potent antiprotozoal activities in vitro against Plasmodium falciparum and Leishmania donovani. The selectivity of the extracts was also evaluated by testing cytotoxicity on a mammalian L6 cell line. The ethyl acetate extract of the brown seaweed, Bifurcaria bifurcata, showed strong trypanocidal activity with a mild selectivity index (IC(50) = 0.53 µg/mL; selectivity index (SI) = 11.6). Bio-guided fractionation led to the isolation of eleganolone, the main diterpenoid isolated from this species. Eleganolone contributes only mildly to the trypanocidal activity of the ethyl acetate extract (IC(50) = 45.0 µM, SI = 4.0). However, a selective activity against P. falciparum erythrocytic stages in vitro has been highlighted (IC(50) = 7.9 µM, SI = 21.6).
Collapse
Affiliation(s)
- Jean-Baptiste Gallé
- UMR 7200 CNRS, Therapeutic Innovation Laboratory, Faculty of Pharmacy, University of Strasbourg, 64701 Illkirch, France; E-Mails: (J.-B.G.); (A.L.)
| | - Barthélémy Attioua
- Department of Material Structure Sciences and Technology, University of Cocody, 01 BP 582, Abidjan, Ivory Coast; E-Mail:
| | - Marcel Kaiser
- Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland; E-Mail:
- University of Basel, Petersplatz 1, 4003 Basel, Switzerland
| | - Anne-Marie Rusig
- CNRS INEE-FRE3484 Marine Mollusks Biology and Associated Ecosystems, University of Caen Basse-Normandie, 14032 Caen Cedex, France; E-Mail:
| | - Annelise Lobstein
- UMR 7200 CNRS, Therapeutic Innovation Laboratory, Faculty of Pharmacy, University of Strasbourg, 64701 Illkirch, France; E-Mails: (J.-B.G.); (A.L.)
| | - Catherine Vonthron-Sénécheau
- UMR 7200 CNRS, Therapeutic Innovation Laboratory, Faculty of Pharmacy, University of Strasbourg, 64701 Illkirch, France; E-Mails: (J.-B.G.); (A.L.)
| |
Collapse
|